Results 201 to 210 of about 176,568 (258)

Immune history confers antibody- and T cell-dependent cross-protection against highly pathogenic avian influenza H5N1 viruses. [PDF]

open access: yesJ Virol
Brigleb PH   +17 more
europepmc   +1 more source

Cross-sectional study on protective antibodies against influenza A virus subtypes and cross-protection against influenza A(H3N2) subclade K, Portugal, August 2025. [PDF]

open access: yesEuro Surveill
Guiomar R   +8 more
europepmc   +1 more source

Interim 2025/26 influenza vaccine effectiveness estimates with immuno-epidemiological considerations for A(H3N2) subclade K protection, Canada, January 2026. [PDF]

open access: yesEuro Surveill
Separovic L   +18 more
europepmc   +1 more source

2009-H1N1

open access: yes, 2012
openaire   +1 more source

Clinical Serum-Anchored Computational Design Pipeline for a Broad-Spectrum Influenza Multi-Epitope mRNA Vaccine. [PDF]

open access: yesBiology (Basel)
Yuan L   +14 more
europepmc   +1 more source

Intranasal Mosaic H1N1 Live Attenuated Influenza Vaccine Elicits Broad Cross-Reactive Immunity and Protection Against Group 1 and 2 Influenza A Viruses. [PDF]

open access: yesMedComm (2020)
Ma X   +16 more
europepmc   +1 more source

Confined Synthesis of Axial Chlorine Coordinated Single-Atom Nanozyme Within Liposomes for Sensitive Immunoassay. [PDF]

open access: yesNanomicro Lett
Chu C   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy